6,061 filings
Page 38 of 100
6-K
op0xmy
15 Jul 20
Fda Panel Votes In Favor of Belantamab Mafodotin
6:30am
3/A
jv13g45z
14 Jul 20
Initial statement of insider ownership (amended)
4:48pm
6-K
1wf4i95
14 Jul 20
Director/pdmr Shareholding
1:59pm
6-K
418tapdpo2s5twv9bc
13 Jul 20
Director/pdmr Shareholding
1:27pm
SC 13D/A
ay9 z0sd8uo
10 Jul 20
CRISPR Therapeutics / GLAXOSMITHKLINE ownership change
5:26pm
6-K
etwpacl43171d
10 Jul 20
Director/pdmr Shareholding
1:05pm
6-K
9119f5 dg9gmu
10 Jul 20
Director/pdmr Shareholding
12:25pm
6-K
jmf8skx
10 Jul 20
Director/pdmr Shareholding
12:17pm
3
yyvhhpljo6a3futcph
9 Jul 20
Initial statement of insider ownership
8:58pm
11-K
dl7yv9sqt
2 Jul 20
Annual report of employee stock purchases
12:00am
11-K
mled5v chce3
2 Jul 20
Annual report of employee stock purchases
12:00am
6-K
484r8mzywn46jqcjf
1 Jul 20
Total Voting Rights
8:46am
6-K
8yn 70zu9
29 Jun 20
GSK'S Daprodustat Gains First Regulatory Approval
6:50am
SC 13D/A
7b7jr2xsg22
29 Jun 20
Morphic Holding / GLAXOSMITHKLINE ownership change
12:00am
4
g23m0ax6tkd4yyxc4tqt
22 Jun 20
Change in insider ownership
5:29pm
SC 13D/A
qrad07o ob
22 Jun 20
Theravance Biopharma / GLAXOSMITHKLINE ownership change
5:13pm
6-K
cebbf5a98wferzitxa6
19 Jun 20
Fda Advisory Committee Review Belantamab Mafodotin
10:55am
6-K
90l0nm 0e
18 Jun 20
Current report (foreign)
12:41pm
6-K
tsah5wp91b
18 Jun 20
Director/pdmr Shareholding
8:46am
6-K
i8iogf4
17 Jun 20
Current report (foreign)
4:17pm